Review



651 cd45ro viogreen  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Miltenyi Biotec 651 cd45ro viogreen
    651 Cd45ro Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 89 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/651 cd45ro viogreen/product/Miltenyi Biotec
    Average 95 stars, based on 89 article reviews
    651 cd45ro viogreen - by Bioz Stars, 2026-03
    95/100 stars

    Images



    Similar Products

    95
    Miltenyi Biotec 651 cd45ro viogreen
    651 Cd45ro Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/651 cd45ro viogreen/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    651 cd45ro viogreen - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    NSJ Bioreagents cd45ro antibody
    Cd45ro Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ro antibody/product/NSJ Bioreagents
    Average 99 stars, based on 1 article reviews
    cd45ro antibody - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec cd45ra cd45ro cxcr5 nt reg
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Cd45ra Cd45ro Cxcr5 Nt Reg, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ra cd45ro cxcr5 nt reg/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    cd45ra cd45ro cxcr5 nt reg - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec cd45ra cd45ro cxcr5 pretfr cells
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Cd45ra Cd45ro Cxcr5 Pretfr Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ra cd45ro cxcr5 pretfr cells/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    cd45ra cd45ro cxcr5 pretfr cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd45ro apc
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Anti Cd45ro Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd45ro apc/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti cd45ro apc - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec anti human cd45ro
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Anti Human Cd45ro, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd45ro/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti human cd45ro - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    97
    Akoya Biosciences cd45ro
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Cd45ro, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ro/product/Akoya Biosciences
    Average 97 stars, based on 1 article reviews
    cd45ro - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Journal: Science Advances

    Article Title: Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections

    doi: 10.1126/sciadv.adv6939

    Figure Lengend Snippet: ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Article Snippet: For in vitro cell expansion, 4 × 10 3 CD45RA + CD45RO − CXCR5 − nT reg or 3 × 10 3 CD45RA + CD45RO − CXCR5 + preTfr cells were activated by human T reg expander beads (Miltenyi Biotec) and cytokine cocktails of IL-2 (500 IU/ml; Shionogi), activin A (100 ng/ml; PeproTech), and IL-12 (1 ng/ml; PeproTech).

    Techniques: Flow Cytometry, Expressing, Gene Expression, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Suppression Assay, Comparison

    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Journal: Science Advances

    Article Title: Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections

    doi: 10.1126/sciadv.adv6939

    Figure Lengend Snippet: ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Article Snippet: For in vitro cell expansion, 4 × 10 3 CD45RA + CD45RO − CXCR5 − nT reg or 3 × 10 3 CD45RA + CD45RO − CXCR5 + preTfr cells were activated by human T reg expander beads (Miltenyi Biotec) and cytokine cocktails of IL-2 (500 IU/ml; Shionogi), activin A (100 ng/ml; PeproTech), and IL-12 (1 ng/ml; PeproTech).

    Techniques: Flow Cytometry, Expressing, Gene Expression, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Suppression Assay, Comparison